A case of cicatricial alopecia associated with erlotinib

Annals of Dermatology

Volumn 23, Issue SUPPL. 3, 2011, Pages

  Yang, Bo Hee ^a   Bang, Chan Yl ^a   Byun, Ji Won ^a   Han, Sung Hyub ^a   Song, Hee Jin ^a   In, Seung Gyun ^a   Shin, Jeong Hyun ^a   Choi, Gwang Seong ^a  

^a Inha University School of Medicine   (South Korea)

Author keywords

Cicatricial alopecia; Epidermal growth factor receptor; Erlotinib

Indexed keywords

EID: 84857417700     PISSN: 10139087     EISSN: None     Source Type: Journal    
DOI: 10.5021/ad.2011.23.S3.S350     Document Type: Article

References (11)

1. Pongpudpunth M, Demierre MF, Goldberg LJ. A case report of inflammatory nonscarring alopecia associated with the epidermal growth factor receptor inhibitor erlotinib. J Cutan Pathol 2009;36:1303-1307.
2. Costa DB, Kobayashi S, Schumer ST. Erlotinib-associated alopecia in a lung cancer patient. J Thorac Oncol 2007;2:1136-1138. (Pubitemid 350307913)
3. Li T, Perez-Soler R. Skin toxicities associated with epidermal growth factor receptor inhibitors. Target Oncol 2009;4:107-119.
4. Langer C, Soria JC. The role of anti-epidermal growth factor receptor and anti-vascular endothelial growth factor therapies in the treatment of non-small-cell lung cancer. Clin Lung Cancer 2010;11:82-90.
5. Donovan JC, Ghazarian DM, Shaw JC. Scarring alopecia associated with use of the epidermal growth factor receptor inhibitor gefitinib. Arch Dermatol 2008;144:1524-1525.
6. Graves JE, Jones BF, Lind AC, Heffernan MP. Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinib. J Am Acad Dermatol 2006;55:349-353. (Pubitemid 44038007)
7. Robert C, Soria JC, Spatz A, Le Cesne A, Malka D, Pautier P, et al. Cutaneous side-effects of kinase inhibitors and blocking antibodies. Lancet Oncol 2005;6:491-500. (Pubitemid 40903630)
8. Agero AL, Dusza SW, Benvenuto-Andrade C, Busam KJ, Myskowski P, Halpern AC. Dermatologic side effects associated with the epidermal growth factor receptor inhibitors. J Am Acad Dermatol 2006;55:657-670. (Pubitemid 44436627)
9. Kimyai-Asadi A, Jih MH. Follicular toxic effects of chimeric anti-epidermal growth factor receptor antibody cetuximab used to treat human solid tumors. Arch Dermatol 2002;138:129-131. (Pubitemid 34056253)
10. Hoekzema R, Drillenburg P. Folliculitis decalvans associated with erlotinib. Clin Exp Dermatol 2010;35:916-918.
11. McElwee KJ. Etiology of cicatricial alopecias: a basic science point of view. Dermatol Ther 2008;21:212-220. (Pubitemid 352009066)